-
EP3801457
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3801457
| EP3801457 - STABLE PHARMACEUTICAL COMPOSITIONS FOR PRESSURIZED METERED DOSE INHALERS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 12.03.2021 Database last updated on 31.08.2024 | |
| Former | The international publication has been made Status updated on 14.12.2019 | ||
| Former | unknown Status updated on 29.06.2019 | Most recent event Tooltip | 12.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Lupin Inc. 4006 NW 124th Avenue Coral Springs, Florida 33065 / US | [2021/15] | Inventor(s) | 01 /
DALVI, Mukul c/o Lupin Inc. 4006 NW 124th Avenue Coral Springs, Florida 33065 / US | 02 /
GUPTA, Abhishek c/o Lupin Inc. 4006 NW 124th Avenue Coral Springs, Florida 33065 / US | 03 /
COLOMBANI, Agnes c/o Lupin Inc. 4006 NW 124th Avenue Coral Springs, Florida 33065 / US | [2021/15] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [N/P] |
| Former [2021/15] | J A Kemp LLP 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 19732190.4 | 04.06.2019 | [2021/15] | WO2019US35362 | Priority number, date | US201862680173P | 04.06.2018 Original published format: US 201862680173 P | [2021/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019236559 | Date: | 12.12.2019 | Language: | EN | [2019/50] | Type: | A1 Application with search report | No.: | EP3801457 | Date: | 14.04.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.12.2019 takes the place of the publication of the European patent application. | [2021/15] | Search report(s) | International search report - published on: | EP | 12.12.2019 | Classification | IPC: | A61K9/00, A61K31/167, A61K31/573, A61K45/06, A61P11/00, A61P11/02, A61P11/06, A61P11/08 | [2021/15] | CPC: |
A61K45/06 (EP);
A61K31/137 (US);
A61K31/167 (EP);
A61K31/401 (US);
A61K31/4748 (US);
A61K31/573 (EP);
A61K31/575 (US);
A61K47/06 (US);
A61K47/10 (US);
A61K47/12 (US);
A61K9/008 (EP);
A61M15/0001 (US);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P11/08 (EP)
(-)
| C-Set: |
A61K31/167, A61K2300/00 (EP);
A61K31/573, A61K2300/00 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/15] | Extension states | BA | 16.12.2020 | ME | 16.12.2020 | Validation states | MA | 16.12.2020 | MD | 16.12.2020 | TN | 16.12.2020 | Title | German: | STABILE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN FÜR DRUCKDOSIERINHALATOREN | [2021/15] | English: | STABLE PHARMACEUTICAL COMPOSITIONS FOR PRESSURIZED METERED DOSE INHALERS | [2021/15] | French: | COMPOSITIONS PHARMACEUTIQUES STABLES POUR INHALATEURS DOSEURS SOUS PRESSION | [2021/15] | Entry into regional phase | 16.12.2020 | National basic fee paid | 16.12.2020 | Designation fee(s) paid | 16.12.2020 | Examination fee paid | Examination procedure | 16.12.2020 | Examination requested [2021/15] | 16.12.2020 | Date on which the examining division has become responsible | 02.08.2021 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.06.2021 | Renewal fee patent year 03 | 21.06.2022 | Renewal fee patent year 04 | 27.06.2023 | Renewal fee patent year 05 | 12.06.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2004019985 (CIPLA LTD [IN], et al) [X] 1,4-11,13-19 * examples 9, 30 *; | [X]WO2007020204 (BOEHRINGER INGELHEIM PHARMA [DE], et al) [X] 1-4,6-10,12,13,16-19 * examples A-F *; | [XD]EP1787639 (CHIESI FARMA SPA [IT]) [XD] 1,4,6-12,17-19* example 1 *; | [X]WO2012007729 (CIPLA LTD [IN], et al) [X] 1,4-19 * examples 14-15, 17, 25-26, 28 *; | [X]WO2012049444 (CIPLA LTD [IN], et al) [X] 1,4-19 * examples 6, 15, 36, 37, 39 *; | [X]EP2486914 (PABLO CASSARA S R L LAB [AR]) [X] 1-19 * examples 1-4; tables 1-5 *; | [X]WO2012110770 (CIPLA LTD [IN], et al) [X] 1,4-19 * examples 6-7, 9, 19, 29, 39, 49 *; | [X]WO2017093755 (MEXICHEM FLUOR SA DE CV [MX], et al) [X] 1,4-10,13-15,17-19 * examples 1, 3; tables 3A, 4A, 4B, 5A, 5B * | by applicant | EP1660035 | US2006140873 | EP1787639 | EP2010190 | EP2223682 |